Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:37 PM
Ignite Modification Date:
2025-12-24 @ 3:37 PM
NCT ID:
NCT04570592
Eligibility Criteria:
Inclusion Criteria:
* American Society of Anaesthesiologists (ASA) I-II category
* 2 risks factors or more for PONV according to Apfel Score.
Exclusion Criteria:
* Unfit for spinal anaesthesia.
* Coagulopathy
* Uncorrected hypovolemia
* Indeterminate neurologic disease
* Infection at site of injection
* Raised intracranial pressure(ICP)
* Morbidly obese patients, BMI\> 40 kg/m2 according to ICD-10 (International Statistical Classification of Diseases 10)
* Patients allergic towards morphine.
* Contraindicated for antiemetics use
* Granisetron: allergy towards Granisetron, prolonged QT interval
* Ondansetron: allergy towards ondansetron, prolonged QT interval
* Dexamethasone: allergy towards Dexamethasone, uncontrolled Diabetes Mellitus (DM).
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
45 Years
Study:
NCT04570592
Study Brief:
Protocol Section:
NCT04570592